Table 1 Characteristics of patients and embolized devices
From: Urgent surgical management for embolized occluder devices in childhood: single center experience
Case No: | Age (Years) | Primary disease | BSA (m2) | Defect size (mm) | Qp/Qs | Embolized device and size (mm) | Embolization site | Timing of event |
|---|---|---|---|---|---|---|---|---|
1 | 4 | ASD | 0.66 | 20 | 6.08 | Amplatzer® 9-PFO-024(38–34) | Tricuspid valve | 1 day |
2 | 8 | ASD | 0.84 | 19 | 5 | Amplatzer® 9-PFO-022(32–36) | Right ventricle | 1 day |
3 | 9 | ASD | 0.9 | 22 | 11 | Amplatzer® 9-PFO-026(36–40) | Left ventricle | Peroperative |
4 | 15 | ASD | 1.26 | 27 | 3.5 | Amplatzer® 9-PFO-019(29–33) | Pulmonary valve | 1 day |
5 | 15 | ASD | 1.57 | 27-28 | 4 | Amplatzer® 9-PFO-028(38–42) | Right atrium | Peroperative |
6 | 9 | ASD | 1.08 | 10 | 1.5 | Biostar BSR-28 | Tricuspid valve | 2 days |
7 | 8 | PDA | 0.81 | 4.5 | 1.4 | Amplatzer® 9-PDA006(10–8) | Ascending Aorta | Peroperative |
8 | 2 | PDA | 0.45 | 4.55 | 3.1 | Amplatzer® Nit.Ocluder(9–6) | Tricuspid valve | Peroperative |
9 | 10 | mVSD | 0.79 | 7 | 2.2 | Amplatzer® 9-VSDmusc-008(16) | Tricuspid Valve | Peroperative |